Načítá se...
Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review
The atypical antipsychotics (AAPs) have been used as first-line drugs in psychiatric practice for a wide range of psychotic disorders, including schizophrenia and bipolar mania. While effectively exerting therapeutic effects on positive and negative symptoms, as well as cognitive impairments in schi...
Uloženo v:
| Vydáno v: | Neuropsychiatr Dis Treat |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6659786/ https://ncbi.nlm.nih.gov/pubmed/31413575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S208061 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|